Dublin, Ireland

Orla Cunningham

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Orla Cunningham: Innovator in Antibody Therapeutics

Introduction

Orla Cunningham is a distinguished inventor based in Dublin, Ireland. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 3 patents to her name, her work focuses on innovative solutions for treating diseases.

Latest Patents

Cunningham's latest patents include groundbreaking inventions related to tumor necrosis factor-like ligand 1A specific antibodies. These patents provide antibodies, or antigen-binding fragments thereof, that specifically bind to tumor necrosis factor (TNF)-like ligand (TL1A). The inventions also detail methods for obtaining such antibodies and nucleic acids encoding them. Furthermore, they relate to compositions and therapeutic methods for using these antibodies in the treatment and prevention of TL1A-mediated diseases, disorders, or conditions.

Career Highlights

Throughout her career, Orla Cunningham has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Bristol-Myers Squibb Company. Her experience in these organizations has allowed her to develop her expertise in antibody therapeutics and contribute to significant advancements in the field.

Collaborations

Cunningham has collaborated with notable professionals in her field, including Robert Arch and Jun Zhang. These partnerships have further enhanced her research and development efforts, leading to innovative solutions in biotechnology.

Conclusion

Orla Cunningham is a remarkable inventor whose work in antibody therapeutics has the potential to impact the treatment of various diseases. Her patents and collaborations reflect her dedication to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…